Dr. Reddy’s Q1 net slides 36% on impairment charge
The Hindu
Drugmaker sets aside Rs. 193 crore after losing U. S. arbitration case
Pharma major Dr. Reddy’s Laboratories on Tuesday reported that the first-quarter consolidated net profit declined by 36% to Rs.380.4 crore, from Rs.594.6 crore in the earlier period of the year. Revenue from operations rose almost by 12% to Rs.4,945.1 Crore in the three months ending in June (Rs.4,426.5 crore), with net sales also increasing by a similar extent to Rs.4,826.2 crore (Rs.4,324.4 crore). Total income at Rs.5,053 crore (Rs.4,513.6 crore) was an increase of almost 12%, according to the results prepared as per Indian Accounting Standards (Ind A. S).
February 2025 saw a 2% increase in passenger vehicle sales in India, with upcoming festivals expected to boost demand.
Fitch Ratings revises outlook on Adani Group entities to Stable, affirms 'BBB-' rating, and takes rating action on other bonds.
Equity market benchmarks Sensex and Nifty rise on strong domestic data and global trends, led by ICICI Bank and Reliance: Follow The Hindu’s updates on the Sensex and Nifty
Scopely will pay $3.5 billion to acquire Niantic’s game unit, including the studio behind Pokemon Go.
Follow The Hindu’s updates on the rupee : Mumbai forex analysts report on rupee's gains against the dollar amid global tariff tensions and economic data.
The U.S. Federal Trade Commission is moving ahead with an antitrust probe of Microsoft, Bloomberg News reported.
Intel hires semiconductor industry veteran Lip-Bu Tan as CEO to revive struggling company amid leadership changes and financial challenges.
Nandan Nilekani predicts India as top IPO market by 2035 with 1 million startups and $8 trillion economy potential.
BNW Developments partners with Taj to bring luxury living to UAE's Al Marjan Island, Ras Al Khaimah.
Equity indices Sensex and Nifty close lower amid global economic concerns, with IT and telecom stocks leading the decline.
Rupee closes at 87.19 against US dollar amid tariff uncertainties, crude oil prices, and global market volatility.
NCLAT rejects IRDA pleas against Shriram Group insurance arm mergers, citing no statutory bar under Insurance Act.
TIVOLT Electric Vehicles inaugurates e-SCV manufacturing plant in Chennai with high-performance EVIATOR for sustainable transportation solutions.